Riddargatan 19
Stockholm 11457
Sweden
https://vimian.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 1,100
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Patrik Eriksson | Chief Executive Officer | 415k | N/A | 1967 |
Mr. Carl-Johan Zetterberg Boudrie | Chief Financial Officer | N/A | N/A | 1978 |
Ms. Maria Dahllof Tullberg | Head of IR, Communications & Sustainability | N/A | N/A | 1981 |
Mr. Carl-Johan Ehn | General Counsel | N/A | N/A | 1974 |
Mr. Magnus Kjellberg | Chief Executive Officer of Nextmune | N/A | N/A | 1973 |
Mr. Martin Bengtson | Head of M&A | N/A | N/A | N/A |
Mr. Stefano Santarelli | Chief Executive Officer of Indical Bioscience | N/A | N/A | 1981 |
Mr. Guy C. Sporri | Chief Executive Officer of Movora | N/A | N/A | 1980 |
Mr. Alireza Tajbakhsh | Head & CEO of VetFamily | N/A | N/A | 1983 |
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
Vimian Group AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.